Haemoglobinopathies congenital Recruiting Phase 2 Trials for Busulfan (DB01008)

Also known as: Hemoglobinopathy / Haemoglobinopathies / Hemoglobinopathies / Haemoglobinopathy / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02349906Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant DiseasesTreatment